ADAM10 and Dimebolin

Funding year(s): 
2009
Funding to date: 
$150,000

Understanding the hypothesized relationship between ADAM10, a newly identified Alzheimer’s-related gene, and dimebolin, the key ingredient in the anti-Alzheimer’s drug Dimebon.

Roadmap: 
Researchers: